ClinicalTrialsFinder

Phase 3 Limited Stage Small Cell Lung Cancer Clinical Trials

3 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–3 of 3 trials

Recruiting
Phase 3

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

Small Cell Lung CancerLimited Stage Small Cell Lung Cancer
Amgen400 enrolled204 locationsNCT06117774
Recruiting
Phase 2Phase 3

Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT

Limited Stage Small Cell Lung Cancer
Sun Yat-sen University346 enrolled1 locationNCT05623267
Recruiting
Phase 3

Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy

Limited Stage Small Cell Lung Cancer
Shandong Cancer Hospital and Institute534 enrolled2 locationsNCT04829708